Skip to main content
Clinical Trials/CTRI/2020/02/023495
CTRI/2020/02/023495
Not yet recruiting
未知

A prospective observational study on the efficacy and side effects of oral KUVA ( khellin UV A) SOL therapy in stable vitiligo patients.

Dr Lavin Bhatia0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Dr Lavin Bhatia
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Sponsor
Dr Lavin Bhatia

Eligibility Criteria

Inclusion Criteria

  • 1\.Patients with stable lesions.
  • 2\.Patients between 18 and 60 years of age.
  • 3\.Patients who give informed consent for the study and photography.
  • 4\.Patients who can follow up in the opd

Exclusion Criteria

  • 1\.Patients who are unwilling to participate in the study.
  • 2\.Patients who had used any topical treatment 2 weeks and systemic treatment 4 weeks before starting on KUVA SOL.
  • 3\.Patients with history of photosensitive disorders, skin cancer, hepatic or renal disease and lesions over genitals.
  • 4\.Pregnant or lactating women.
  • 5\.Unstable vitiligo.
  • 6\.Patients with spontaneous repigmentation of depigmented macules.

Outcomes

Primary Outcomes

Not specified

Similar Trials